Document ID: chunk:federal_register_of_legislation:F2022C00898:front:0:p5
Version: federal_register_of_legislation:F2022C00898
Segment Type: other
Provision Reference: 
Character Range: 11571–14688

of diabetes mellitus;
(q)          having anti-androgen therapy as specified for at least the one year before the clinical onset of diabetes mellitus;
             Note: anti-androgen therapy as specified is defined in the Schedule 1 - Dictionary.
(r)           being exposed to arsenic as specified before the clinical onset of diabetes mellitus;
             Note: being exposed to arsenic as specified is defined in the Schedule 1 - Dictionary.
(s)           inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD):
(i)            for a cumulative period of at least 500 hours, within a consecutive period of ten years before the clinical onset of diabetes mellitus; and
(ii)         where the first exposure occurred at least five years before the clinical onset of diabetes mellitus; and
(iii)       where that exposure has ceased, the clinical onset of diabetes mellitus has occurred within 25 years of cessation; or
               Note: inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) is defined in the Schedule 1 - Dictionary.
(t)            for parous women only, inability to breast feed for a cumulative period of at least six months before the clinical onset of diabetes mellitus;
             Note: The period of breastfeeding could be cumulative over a number of pregnancies.
(8)          for gestational diabetes mellitus and type 2 diabetes mellitus only, being pregnant at the time of the clinical onset of diabetes mellitus;
(9)          having an endocrine disorder from the specified list of endocrine disorders before the clinical worsening of diabetes mellitus;
            Note: specified list of endocrine disorders is defined in the Schedule 1 - Dictionary.
(10)      having a solid organ transplant or bone marrow transplant before the clinical worsening of diabetes mellitus;
(11)      having glucocorticoid therapy as specified, before the clinical worsening of diabetes mellitus, and where the glucocorticoid therapy as specified has ceased or decreased, the last dose of the therapy was received within the 30 days before the clinical worsening of diabetes mellitus;
            Note: glucocorticoid therapy as specified is defined in the Schedule 1 - Dictionary.
(12)      being treated with a drug from the Specified List 1 of drugs, which cannot be ceased or substituted, for at least the seven days before the clinical worsening of diabetes mellitus;
            Note: Specified List 1 of drugs is defined in the Schedule 1 - Dictionary.
(13)      being treated with a drug from the antidepressant or antipsychotic classes of drugs, which cannot be ceased or substituted, for at least the six weeks before the clinical worsening of diabetes mellitus;
(13a) taking an immune checkpoint inhibitor or an interferon within the one year before the clinical worsening of diabetes mellitus;
            Note: immune checkpoint inhibitor is defined in the Schedule 1 - Dictionary
(14)      undergoing surgery to the pancreas before